Mirum Pharmaceuticals, Inc. (MIRM)
96.74
+0.44
(+0.45%)
USD |
NASDAQ |
Aug 24, 16:00
96.74
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Liabilities (Quarterly) : 1.055B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.055B |
| March 31, 2026 | 648.42M |
| December 31, 2025 | 528.12M |
| September 30, 2025 | 493.07M |
| June 30, 2025 | 470.67M |
| March 31, 2025 | 456.99M |
| December 31, 2024 | 445.11M |
| September 30, 2024 | 435.87M |
| June 30, 2024 | 431.77M |
| March 31, 2024 | 417.36M |
| December 31, 2023 | 397.95M |
| September 30, 2023 | 381.56M |
| June 30, 2023 | 364.98M |
| March 31, 2023 | 192.38M |
| December 31, 2022 | 210.87M |
| Date | Value |
|---|---|
| September 30, 2022 | 195.05M |
| June 30, 2022 | 186.55M |
| March 31, 2022 | 169.22M |
| December 31, 2021 | 174.44M |
| September 30, 2021 | 178.77M |
| June 30, 2021 | 151.93M |
| March 31, 2021 | 88.36M |
| December 31, 2020 | 68.77M |
| September 30, 2020 | 21.61M |
| June 30, 2020 | 19.56M |
| March 31, 2020 | 16.68M |
| December 31, 2019 | 16.36M |
| September 30, 2019 | 12.07M |
| June 30, 2019 | 12.39M |
| March 31, 2019 | 7.713M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.528B |
| Insmed, Inc. | 1.345B |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| BioMarin Pharmaceutical, Inc. | 5.402B |
| Ionis Pharmaceuticals, Inc. | 2.555B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.045B |
| Shareholders Equity (Quarterly) | -10.42M |
| Debt to Equity Ratio | -73.21 |
| Current Ratio | 2.856 |
| Net Debt Paydown Yield | -1.18% |